Does Blue Cross Blue Shield of Illinois Cover Cialis?

How BCBSIL Formulary Coverage Works for Tadalafil

Blue Cross Blue Shield of Illinois organizes prescription drugs into tiers that determine your out-of-pocket cost. Where tadalafil lands on that tier list controls how much you pay at the pharmacy counter. Most BCBSIL commercial plans adopted generic tadalafil after Cialis lost patent exclusivity in September 2018 [1].

Tier Placement for Generic Tadalafil

On the majority of BCBSIL commercial HMO and PPO formularies, generic tadalafil appears at Tier 2 (preferred brand) or Tier 3 (non-preferred generic). Tier 2 placement typically carries a copay between $20 and $45 per 30-day fill. Tier 3 placement pushes that copay toward $50 to $75, or 25% to 40% coinsurance on some plans. Your specific plan documents, available through the BCBSIL member portal, list the exact tier [2].

Brand-Name Cialis: Mostly Excluded

Brand Cialis (manufactured by Eli Lilly) is excluded from most BCBSIL preferred drug lists as of 2025. When a plan does list it, the drug sits on Tier 4 or the specialty tier. Out-of-pocket costs for brand Cialis without a formulary exception can exceed $400 for a 30-day supply. The FDA's Orange Book lists multiple approved generic manufacturers, which is why insurers have shifted coverage to the generic form [3].

Marketplace and ACA Plans

BCBSIL marketplace plans sold on the Illinois Health Insurance Marketplace follow Essential Health Benefit rules but are not required to cover erectile dysfunction medications under federal mandate. Several Silver and Gold BCBSIL marketplace plans do include generic tadalafil, but Bronze plans may exclude it entirely. Checking the plan's Summary of Benefits and Coverage (SBC) before open enrollment is the most reliable way to confirm ED drug coverage.

Prior Authorization and Step Therapy Requirements

BCBSIL applies utilization management tools to erectile dysfunction prescriptions. These requirements exist to steer members toward lower-cost options first and to confirm the clinical appropriateness of the medication.

What Prior Authorization Involves

Prior authorization (PA) for tadalafil on BCBSIL plans typically requires documentation of an erectile dysfunction diagnosis, often confirmed by a validated questionnaire such as the IIEF-5 (International Index of Erectile Function) [4]. Your prescribing clinician submits the PA request, and BCBSIL usually responds within 72 hours for non-urgent requests. Approval periods vary from 6 to 12 months, after which the PA must be renewed.

Step Therapy Protocols

Some BCBSIL plans enforce step therapy, requiring a trial of generic sildenafil before approving tadalafil. Sildenafil sits on Tier 1 or Tier 2 on most BCBSIL formularies, making it the lowest-cost PDE5 inhibitor option. If sildenafil proves ineffective, causes intolerable side effects, or is contraindicated (for example, due to a preference for the longer 36-hour activity window of tadalafil), your physician can request a step therapy exception [5].

The American Urological Association (AUA) guidelines on erectile dysfunction state: "All PDE5 inhibitors have similar efficacy, and the choice among them should be based on patient preference, cost, and ease of use" [5]. This recommendation supports exception requests when a patient has a clinical reason to prefer tadalafil over sildenafil.

Quantity Limits

BCBSIL commonly applies quantity limits of 6 to 12 tablets per 30 days for on-demand dosing (10 mg or 20 mg tablets). Daily-dose tadalafil (2.5 mg or 5 mg) is typically approved at 30 tablets per month when prescribed for the combined indication of ED and benign prostatic hyperplasia (BPH). Quantity limit exceptions require clinical documentation.

The Clinical Case for Tadalafil

Tadalafil belongs to the phosphodiesterase type 5 (PDE5) inhibitor class. It works by increasing blood flow to the corpus cavernosum during sexual stimulation. Tadalafil's distinguishing feature is its 17.5-hour half-life, the longest among approved PDE5 inhibitors [6].

Efficacy Data

In a pooled analysis of five randomized controlled trials (N = 2,102), tadalafil 20 mg improved erectile function domain scores on the IIEF by a mean of 7.9 points compared to 1.7 points with placebo (P<0.001) [6]. The drug's 36-hour window of activity allows for more spontaneous timing compared to sildenafil's 4-to-6-hour window.

Daily Dosing for BPH and ED

A 12-week placebo-controlled trial (N = 1,500) published in the Journal of Urology demonstrated that tadalafil 5 mg daily reduced International Prostate Symptom Score (IPSS) by 4.9 points versus 2.3 points with placebo, while simultaneously improving IIEF-EF domain scores [7]. This dual indication is relevant to BCBSIL coverage because plans may approve daily tadalafil under the BPH indication when the ED-only indication is excluded.

Safety Profile

Common adverse effects include headache (11% to 15%), dyspepsia (4% to 13%), back pain (3% to 9%), and nasal congestion (3% to 5%) [6]. Tadalafil is contraindicated with nitrate medications due to the risk of severe hypotension. The FDA prescribing information also warns against combining tadalafil with alpha-blockers without careful dose titration [3].

Dr. Arthur Burnett, Professor of Urology at Johns Hopkins Medicine and a contributor to the AUA erectile dysfunction guidelines, has noted: "PDE5 inhibitors remain the first-line pharmacotherapy for erectile dysfunction, with choice driven by individual patient factors including duration of action, side-effect sensitivity, and frequency of sexual activity" [5].

Cost Breakdown: What Illinois Members Actually Pay

The price you pay for tadalafil through BCBSIL depends on your plan design, pharmacy network, and whether you use mail-order options.

Retail Pharmacy Costs

At preferred network pharmacies in Illinois (CVS, Walgreens, Jewel-Osco), generic tadalafil 20 mg typically runs $20 to $45 per fill of 6 to 12 tablets with Tier 2 coverage. Members on high-deductible health plans (HDHPs) pay the full negotiated rate until meeting their deductible, which can range from $1,600 to $3,200 for individual plans in 2025 [8].

Mail-Order Savings

BCBSIL members enrolled in Prime Therapeutics or CVS Caremark mail-order programs can often obtain a 90-day supply for the equivalent of two copays. For a Tier 2 medication, that translates to roughly $40 to $90 for a three-month supply versus $60 to $135 at retail.

Cash-Pay Alternatives

Even without insurance coverage, generic tadalafil is surprisingly affordable. A GoodRx analysis of Illinois pharmacies shows a median cash price of $0.50 to $3.00 per tablet for generic tadalafil 20 mg as of early 2026. Splitting a 20 mg tablet (with physician approval) for 10 mg dosing cuts costs further. Costco and independent pharmacies consistently rank among the lowest-cost dispensing options [9].

How to Check Your Specific BCBSIL Coverage

Not all BCBSIL plans are the same. Coverage varies by employer group, individual plan selection, and whether you are on a fully insured versus self-funded employer plan.

Step-by-Step Verification

1. Log into your BCBSIL member account at bcbsil.com.
2. Manage to the "Find a Drug" or formulary search tool.
3. Enter "tadalafil" (not "Cialis") to see tier placement.
4. Check for any PA, step therapy, or quantity limit notations.
5. Call the member services number on the back of your card to confirm details.

Self-Funded Employer Plans

About 60% of workers with employer-sponsored coverage in the United States are in self-funded plans, according to the Kaiser Family Foundation 2024 Employer Health Benefits Survey [8]. Self-funded plans use the BCBSIL network but set their own formulary and coverage rules. Your employer's benefits team, not BCBSIL directly, makes the final coverage decision for these plans.

Appealing a Denial

If BCBSIL denies coverage for tadalafil, you have the right to a formal appeal. The Illinois Department of Insurance requires insurers to process internal appeals within 30 days for non-urgent requests. External review through an independent review organization (IRO) is available if the internal appeal fails. Success rates for ED medication appeals increase significantly when the prescriber documents contraindications to alternative PDE5 inhibitors or treatment failure on step-therapy agents.

Tadalafil for Non-ED Indications on BCBSIL

Tadalafil has FDA approval for three distinct indications, and coverage rules differ for each.

Erectile Dysfunction (ED)

The most common indication. Coverage rules described above apply. On-demand dosing at 10 mg or 20 mg is standard.

Benign Prostatic Hyperplasia (BPH)

Tadalafil 5 mg daily is FDA-approved for BPH symptoms. BCBSIL may cover this under the urology benefit without the same restrictions applied to the ED indication. A 2012 study published in European Urology confirmed tadalafil's efficacy for lower urinary tract symptoms associated with BPH in a 12-week multicenter trial (N = 581), with significant improvement in total IPSS score versus placebo (P<0.001) [10].

Pulmonary Arterial Hypertension (PAH)

Tadalafil is marketed under the brand name Adcirca (20 mg, once-daily dosing at 40 mg total) for PAH. This indication is typically covered under the specialty pharmacy benefit with prior authorization. The PHIRST-1 trial (N = 405) demonstrated that tadalafil 40 mg daily improved 6-minute walk distance by 33 meters compared to placebo in treatment-naive PAH patients [11]. BCBSIL specialty pharmacy programs usually manage Adcirca separately from the standard drug formulary.

Alternatives If BCBSIL Does Not Cover Tadalafil

When coverage is denied or copays are too high, several alternatives exist.

Other Covered PDE5 Inhibitors

Generic sildenafil is the most widely covered PDE5 inhibitor across BCBSIL plans. It sits on Tier 1 on many formularies with copays as low as $3 to $15. Generic vardenafil (Levitra) may also be available at a lower tier than tadalafil on some plans.

Compounded Tadalafil

Some patients access compounded tadalafil through 503B outsourcing pharmacies. These formulations are not FDA-approved as individual products, but the compounding pharmacies operate under FDA regulations for outsourcing facilities [12]. Insurance rarely covers compounded medications, but cash prices can be competitive.

Telehealth and Direct-to-Patient Options

Telehealth platforms, including HealthRX, offer tadalafil prescriptions with transparent cash pricing. This approach bypasses insurance entirely and can be cost-effective for patients on plans with high deductibles or ED medication exclusions. Prices through telehealth dispensing typically range from $1 to $3 per tablet for generic tadalafil.

Patient Assistance and Discount Programs

While Eli Lilly discontinued the Cialis manufacturer coupon program following generic entry, GoodRx, RxSaver, and similar aggregators consistently offer generic tadalafil at $15 to $30 for 30 tablets at Illinois pharmacies. These programs work regardless of insurance status [9].

When to Talk to Your Doctor About Switching

If cost or coverage is a barrier, a prescriber can evaluate whether sildenafil, vardenafil, or avanafil may serve as clinically appropriate alternatives. The AUA guidelines recommend shared decision-making when selecting among PDE5 inhibitors, accounting for onset of action, duration, side-effect profile, and cost [5].

For patients who specifically need tadalafil's long half-life (for example, those with frequent sexual activity or combined ED/BPH symptoms), the prescriber can submit a formulary exception request to BCBSIL with supporting documentation. These requests succeed most often when they include a documented trial of the preferred-tier alternative and a clear clinical rationale for the switch.

A 2020 real-world analysis of 3.4 million commercially insured men with ED prescriptions found that 38% switched PDE5 inhibitors within the first year, most commonly due to insurance formulary changes and cost concerns [13]. Persistence was highest among patients on tadalafil daily dosing, likely because of the dual ED/BPH benefit.